Cellebrite DI Ltd [NASDAQ: CLBT] surged by $1.02 during the normal trading session on while it closed the day at $14.96.
Cellebrite DI Ltd stock has also gained 12.99% of its value over the past 7 days. However, CLBT stock has inclined by 30.43% in the 3 months of the year. Over the past six months meanwhile, it has gained 54.55% and gained 72.75% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for CLBT stock reached $3.07 billion, with 203.23 million shares outstanding and 61.29 million shares in the current float. Compared to the average trading volume of 1.37M shares, CLBT reached a trading volume of 6441381 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Cellebrite DI Ltd [CLBT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLBT shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLBT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Cellebrite DI Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 28, 2024. The new note on the price target was released on March 13, 2024, representing the official price target for Cellebrite DI Ltd stock. Previously, the target price had yet another raise from $9 to $12, while BofA Securities kept a Buy rating on CLBT stock.
The Average True Range (ATR) for Cellebrite DI Ltd is set at 0.64, with the Price to Sales ratio for CLBT stock in the period of the last 12 months amounting to 8.94. Price to Free Cash Flow for CLBT in the course of the last twelve months was 32.69 with Quick ratio for the last quarter at 1.55.
CLBT stock trade performance evaluation
Cellebrite DI Ltd [CLBT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.99. With this latest performance, CLBT shares gained by 16.97% in over the last four-week period, additionally plugging by 54.55% over the last 6 months – not to mention a rise of 94.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLBT stock in for the last two-week period is set at 71.59, with the RSI for the last a single of trading hit 76.23, and the three-weeks RSI is set at 68.74 for Cellebrite DI Ltd [CLBT]. The present Moving Average for the last 50 days of trading for this stock 12.48, while it was recorded at 13.92 for the last single week of trading, and 10.49 for the last 200 days.
Cellebrite DI Ltd [CLBT]: An insightful look at the core fundamentals
Cellebrite DI Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.55 and a Current Ratio set at 1.59.
Earnings per share (EPS) analysis for Cellebrite DI Ltd [CLBT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLBT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cellebrite DI Ltd go to 24.65%.
Cellebrite DI Ltd [CLBT]: Institutional Ownership
The top three institutional holders of CLBT stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in CLBT stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in CLBT stock with ownership which is approximately 5.1238%.
